Abstract
Background
Liver resection is the only potential curative treatment for hilar cholangiocarcinoma. In this article, we evaluate mortality, survival, prognostic factors, and changes in surgical approach during the last two decades at a Western hepato-biliary center.
Methods
Fifty-one patients undergoing liver resections constitute the study population. Patients undergoing palliative procedures were considered as a control group for comparison to the resected group. After 1997, a more aggressive surgical approach was applied that is based on the experience of Japanese surgeons.
Results
Curative resections were achieved in 37 (72.5%) patients, and R1 resections were performed in 14 (27.5%). The overall 3- and 5-year survival rates were 47.3 and 34.1%, respectively. The 3- and 5-year survival rates were 38 and 19% in the R1 resection group, and 15% and 0 in the non-resected group, respectively. Univariate analysis revealed that lymph node and perineural invasion, R1 resection, and a bilirubin level >10 mg/dl affected long-term survival. Multivariate analysis showed that only perineural invasion was significant in affecting long-term survival. Univariate analysis showed that the mean preoperative bilirubin levels and mean blood transfusion were related to the mortality rate. The resectability rate significantly increased from 25 to 75.6% after 1997 following implementation of the new surgical approach.
Conclusions
An aggressive surgical approach increases the resectability rate and may improve long-term survival even after R1 resection. Severe hyperbilirubinemia should be preoperatively drained, possibly by the percutaneous approach.
Similar content being viewed by others
References
Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology. 2003;37(5):961–9.
Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathological features. Am Med. 1965;38:241–56.
Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer. 1998;34:977–86.
Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 2000;7:155–62.
Malhi H, Gores J. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther. 2006;23:1287–96.
Patel T. Cholangiocarcinoma. Gastroenterol Hepatol. 2006;3:33–42.
Neuhaus P, Jonas S, Bechstein WO, et al. Extended resection for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–18.
Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720–7.
Otto G, Romaneehsen B, Hoppe-Lotichius M, Bittinger F. Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging. J Hepatobiliary Pancreat Surg. 2004;11:310–8.
Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg. 2004;139:514–23.
Silva MA, Tekin K, Aytekin F, Bramhall SR, Buckels JA, Mirza DF. Surgery for hilar cholangiocarcinoma: a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol. 2005;31:533–9.
Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005;241:703–12.
Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of respectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 2006;239:113–21.
Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma. Comparison of an American and a Japanese experience. Ann Surg. 2000;232:166–74.
Dinant S, Gerhards M, Rauws E, et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol. 2006;13:872–80.
Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and surgical outcomes of surgical treatment of hilar cholangiocarcinoma. Br J Surg. 2006;93:1488–94.
Strasberg S, Belghiti J, Clavien PA, et al. The Brisbane 2000 terminology of liver anatomy and resection. HPB. 2000;2:333–9.
Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–8.
Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51[Suppl 6]:vi1–9.
Weimann A, Varnholt H, Schlitt HJ, Lang H, Flemming P, Hustedt C, Tusch G, Raab R. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg. 2000;87:1182–7.
Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–17.
Hidalgo E, Asthana S, Nishio H, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34:787–94.
Neuhaus P, Jonas S, Settmacher U, et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases respectability and radicality. Lang Arch Surg. 2003;388:194–200.
Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693–9.
Witzigmann H, Berr F, Ringel U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma. Ann Surg. 2006;244:230–9.
Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2000;7:148–54.
Lee SG, Lee JL, Park KM, Hwang S, Min PC. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg. 2000;7:135–41.
Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemi-hepatic portal vein embolization. Ann Surg. 2003;238:84–92.
Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemi-hepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73–83.
Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95–101.
Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki Y, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240–7.
Miyazaki M, Kato A, Ito H, et al. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery. 2007;141:581–8.
Konstadoulakis MM, Roayaie S, Gomatos IP, et al. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center’s experience. Am J Surg. 2008;196:160–9.
Khan AZ, Makuuchi M. Trends in the surgical management of Klatskin tumors. Br J Surg. 2007;94:393–4.
Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535–43.
Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663–71.
Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and para-aortic node dissection. Ann Surg. 2001;233:385–92.
Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary disease: analysis of 1222 consecutive patients from a prospective disease. Ann Surg. 2004;240:698–708.
Ercolani G, Ravaioli M, Grazi GL, et al. The use of vascular clamping in hepatic surgery: the lesson learned from 1260 liver resections. Arch Surg. 2008;143(4):380–7.
Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S. Risk factors for complications following resection of large gastric cancer. Br J Surg. 2001;88:873–7.
Cherqui D, Benoist S, Malassagne B, et al. Major liver resection for carcinoma in jaundice patients without preoperative biliary drainage. Arch Surg. 2000;135:302–8.
Hochwald SN, Burke EC, Jarnagin WR, Fong Y, Blumgart LH. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 1999;134(3):261–6.
Sewnath ME, Karsten TM, Prins MH, Rauws EAJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002;236:17–27.
Zhang BH, Cheng QB, Luo XJ, et al. Surgical therapy for hilar cholangiocarcinoma: analysis of 198 cases. Hepatobiliary Pancreat Dis Int. 2006;5:278–82.
Halazun KJ, Al-Mukhtar A, Aldouri A, et al. Right hepatic trisectionectomy for hepatobiliary diseases. Results and an appraisal of its current role. Ann Surg. 2007;246:1065–74.
Liu CL, Lo CM, Lai EC, Fan ST. Endoscopic retrograde cholangiopancreatography an endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg. 1998;133:293–6.
Acknowledgments
We especially want to thank Prof. Yuji Nimura for what he taught us about the treatment of bile duct tumors and for his useful revision of our manuscript.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ercolani, G., Zanello, M., Grazi, G.L. et al. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci 17, 329–337 (2010). https://doi.org/10.1007/s00534-009-0249-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00534-009-0249-5